Flavonoid Rich Foods, Such as Tea, May Help Improve Survival in Colorectal Cancer Patients

Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-04-13 14:30 GMT   |   Update On 2023-04-13 14:30 GMT

USA: A new study published in the American Journal of Clinical Nutrition has found that increasing the intake of flavonoids after colorectal cancer (CRC) diagnosis could potentially reduce CRC-specific mortality rates. Despite evidence of anti-cancer effects, the impact of flavonoids on CRC survival remains unclear. The study aims to investigate the association of...

Login or Register to read the full article

USA: A new study published in the American Journal of Clinical Nutrition has found that increasing the intake of flavonoids after colorectal cancer (CRC) diagnosis could potentially reduce CRC-specific mortality rates.

Despite evidence of anti-cancer effects, the impact of flavonoids on CRC survival remains unclear. The study aims to investigate the association of post-diagnostic flavonoid intake with CRC mortality.

The prospective study included 2,552 patients diagnosed with Stage I-III CRC in two cohort studies, who were followed for a total of 31,026 person-years. The patients were assessed for their intake of total flavonoids and their subclasses using validated food frequency questionnaires. The researchers used the inverse probability weighted multivariable Cox proportional hazards regression model to calculate the hazard ratio (HR).

The mean age of patients at diagnosis was 68.7 (9.4) years. During 31,026 person-years of follow-up, 1,689 deaths were documented, of which 327 were due to CRC.

The study found the following key clinical takeaways:

  1. 1.Total flavonoid intake was not associated with mortality.
  2. 2.A higher intake of flavan-3-ol was associated with lower CRC-specific and all-cause mortality.
  3. 3.Tea, which is a major contributor to flavan-3-ol intake, showed an inverse association with CRC-specific and all-cause mortality.
  4. 4.No beneficial associations were found for other flavonoid subclasses.
  5. 5.Spline analysis showed a linear relationship between post-diagnostic flavan-3-ol intake and CRC-specific mortality.

The lead author of the study Dr. Shanshan Shi also noted that “While the study provides important insights into the potential benefits of flavonoids for cancer patients, more research is needed to fully understand their mechanisms of action and how they can be best used in clinical settings.”

The study provides further evidence that diet and lifestyle factors can play an important role in cancer prevention and treatment. Patients diagnosed with CRC may benefit from increasing their intake of flavan-3-ol-rich foods, such as tea, as part of their overall treatment plan.

Reference:

Shi S., Wang K., Zhong R., Ng K., Meyerhardt J., Song M. et al.; Flavonoid intake and survival after diagnosis of colorectal cancer: A prospective study in two US cohorts, American Journal of Clinical Nutrition 2023.04.01; doi: https://doi.org/10.1016/j.ajcnut.2023.03.026

Tags:    
Article Source :  American Journal of Clinical Nutrition

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News